PL370539A1 - Assay - Google Patents

Assay

Info

Publication number
PL370539A1
PL370539A1 PL02370539A PL37053902A PL370539A1 PL 370539 A1 PL370539 A1 PL 370539A1 PL 02370539 A PL02370539 A PL 02370539A PL 37053902 A PL37053902 A PL 37053902A PL 370539 A1 PL370539 A1 PL 370539A1
Authority
PL
Poland
Prior art keywords
assay
Prior art date
Application number
PL02370539A
Other languages
Polish (pl)
Inventor
Pamela May Greengrass
Michael Stewart
Claire Margaret Wood
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0121440.2A external-priority patent/GB0121440D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of PL370539A1 publication Critical patent/PL370539A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL02370539A 2001-09-04 2002-09-04 Assay PL370539A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0121440.2A GB0121440D0 (en) 2001-09-04 2001-09-04 Assay
US32397301P 2001-09-20 2001-09-20

Publications (1)

Publication Number Publication Date
PL370539A1 true PL370539A1 (en) 2005-05-30

Family

ID=26246508

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370539A PL370539A1 (en) 2001-09-04 2002-09-04 Assay

Country Status (8)

Country Link
EP (1) EP1423700A2 (en)
JP (1) JP2005510691A (en)
BR (1) BR0212295A (en)
CA (1) CA2459265A1 (en)
IL (1) IL160674A0 (en)
MX (1) MXPA04002058A (en)
PL (1) PL370539A1 (en)
WO (1) WO2003021271A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701144D0 (en) † 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE10315917A1 (en) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
SE0302775D0 (en) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
US7927820B2 (en) 2004-07-20 2011-04-19 Janssen Pharmaceutica Nv Assay systems and methods for detecting molecules that interact with membrane channels
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
US7776590B2 (en) 2005-12-21 2010-08-17 Roche Palo Alto Llc Stable cell lines expressing hERG

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311300B1 (en) * 2000-07-14 2008-02-27 Merck & Co., Inc. Radioligand and binding assay

Also Published As

Publication number Publication date
WO2003021271A3 (en) 2003-12-18
IL160674A0 (en) 2004-08-31
WO2003021271A2 (en) 2003-03-13
CA2459265A1 (en) 2003-03-13
EP1423700A2 (en) 2004-06-02
JP2005510691A (en) 2005-04-21
MXPA04002058A (en) 2004-06-07
BR0212295A (en) 2004-10-13

Similar Documents

Publication Publication Date Title
HUP0303809A3 (en) Assay system
GB0120126D0 (en) Assay device
EP1442299A4 (en) Assay
EP1470421A4 (en) Rapid prion-detection assay
GB0115777D0 (en) Assay
GB0012860D0 (en) Assay
PL370539A1 (en) Assay
GB0008784D0 (en) Assay
GB0120589D0 (en) Assay
GB0101313D0 (en) Assay
GB0121440D0 (en) Assay
GB0005894D0 (en) Assay
GB0003902D0 (en) Assay
GB0127132D0 (en) Assay
GB0010960D0 (en) Assay
GB0200428D0 (en) Assay
GB0101312D0 (en) Assay
GB0001703D0 (en) Assay
GB0025804D0 (en) Assay
GB0105362D0 (en) Assay
GB0100290D0 (en) Assay
GB0013561D0 (en) Assay
GB0019242D0 (en) Assay
GB0023239D0 (en) Assay
GB0003898D0 (en) Assay

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)